Search results

Explore ANSTO's range of publications and reports available for the public.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.

A 'Challenge-Based Innovation' platform at the nandin Innovation Centre is progressing as part of a funding package from the NSW Government and a Memorandum of Understanding with Swinburne University of Technology and Design Factory Melbourne (DFM).

ANSTO is proud to host the Shorebirds Competition for the fifth year. This unique environmental poster competition is free to enter and offers over $4500 in prizes for students and schools!

New research published in the journal Nature Nanotechnology shows that the next generation of lithium-sulphur (Li||S) batteries may be capable of being charged in less than five minutes, instead of several hours as is currently the case.

Radiation testing of electronic components at ANTO could benefit the aviation industry, regulators and most importantly, passengers as solar radiation events increase.

ANSTO has been awarded a Community Recognition Statement from the NSW State Parliament for hosting an event to launch a new Dharawal language learning resource for preschool and primary-aged students.

Phenomenon predicted by Nobel Prize recipient

Neutron powder diffraction is particularly useful for materials with light elements in the presence of heavy ones and for magnetic materials such as superconductors, pharmaceuticals, aerospace alloys and much more.

See details of previously published customer updates from our Health products team. 

Archive of ANSTO research publications, seminars and short talks.

The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.

ANSTO’s Australian Synchrotron has been working on an initiative that could substantially improve radiotherapy treatment for cancer patients.